Spectral Announces Second Quarter Results and Provides Corporate Update
August 13, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Internal Reorganization of its Wholly Owned Subsidiary Dialco Medical to Enhance Operations and Accelerate Commercialization
August 09, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced an internal reorganization to strengthen the core competencies and...
Spectral Medical Inc. Provides Tigris Clinical Trial Update
July 28, 2021 08:00 ET
|
Spectral Medical Inc.
Recruitment activity returning to normalized levels with 12 trial sites actively screening patients15 sites on track to open for enrollment by the end of Q3 2021 TORONTO, July 28, 2021 (GLOBE...
Spectral Medical Inc. Closes $10 Million Offering of Units
July 27, 2021 09:05 ET
|
Spectral Medical Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 27, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) ("Spectral" or the...
Spectral Medical Inc. Announces $10 Million Offering
July 21, 2021 09:25 ET
|
Spectral Medical Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the...
Spectral Medical Inc. Announces Overnight Marketed Offering
July 20, 2021 16:27 ET
|
Spectral Medical Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the...
Dialco Medical Inc. Engages CROMSOURCE as Contract Research Organization Partner for DIMI IDE Trial
June 07, 2021 08:25 ET
|
Spectral Medical Inc.
TORONTO, June 07, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
June 04, 2021 13:00 ET
|
Spectral Medical Inc.
TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock...
Spectral Announces First Quarter Results and Provides Corporate Update
May 14, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, May 14, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical’s Wholly-Owned Subsidiary Dialco Medical Announces DIMI Usability Trial Posted on the ClinicalTrials.gov Website
May 05, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, May 05, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that the DIMI usability trial, run by its wholly-owned subsidiary, Dialco...